Showing results (61-70 of 135) with videos related to
Sort By:
Pageof 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2019
Declines in Lung Function After Antiretroviral Therapy Initiation in Adults With Human Immunodeficiency Virus and Tuberculosis: A Potential Manifestation of Respiratory Immune Reconstitution Inflammatory SyndromeSara C Auld, Pholo Maenetje, Shruthi Ravimohan, et al.PLOS Global Public Health|July 2, 2024
Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidenceAlberto Matteelli, Gavin Churchyard, Daniela Cirillo, et al.Plos One|February 4, 2022
Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trialRobert S Wallis, Sibuse Ginindza, Trevor Beattie, et al.Trials|October 8, 2022
Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trialAnnelies Van Rie, Elise De Vos, Emilyn Costa, et al.Ebiomedicine|February 20, 2022
The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis riskHumphrey Mulenga, Andrew Fiore-Gartland, Simon C Mendelsohn, et al.The Journal of Infectious Diseases|April 1, 2024
Safety and Immunogenicity of the H56:IC31 Tuberculosis Vaccine Candidate in Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis: A Phase 1 Randomized TrialDereck Tait, Andreas Diacon, Álvaro H Borges, et al.The Journal of Infectious Diseases|August 22, 2023
An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine TrialsPhilip C Hill, Frank Cobelens, Leonardo Martinez, et al.Plos Medicine|February 12, 2026
Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling studyHira Tanvir, Rebecca A Clark, Tom Sumner, et al.The Journal of Infectious Diseases|June 30, 2023
Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung Function in Patients With Human Immunodeficiency Virus and TuberculosisPholo Maenetje, Yeonsoo Baik, Diana B Schramm, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2019
A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and TuberculosisShruthi Ravimohan, Pholo Maenetje, Sara C Auld, et al.Pageof 14